Journals / Gülhane Tıp Dergisi / 2005 / Cilt: 47 - Sayı: 3

New diagnostic approaches into diseases: protein chip technology

Hastalıklara yeni bir tanı yaklaşımı: protein-çip teknolojisi

Pages
243–245
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The protein pattern of a tumor can be demonstrated by using this technology in diseases such as cancer, where several factors and genes are affected, and it is possible to find out more specific and sensitive new cancer markers with this new technology.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:At the beginning of XXIst century, human genome project has been nearly completed.
📊
Key Findings & Data:Today, much more is known about the human genome.
💡
Conclusion & Impact:The protein pattern of a tumor can be demonstrated by using this technology in diseases such as cancer, where several factors and genes are affected, and it is possible to find out more specific and sensitive new cancer markers with this new technology.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Protein dizim analizi · Tanı teknik ve işlemleri · Protein Array Analysis

Abstract

At the beginning of XXIst century, human genome project has been nearly completed. Today, much more is known about the human genome. On the other hand, a new technology named biochip technology has been in use in routine genome analyses. Only one gene region or protein is generally generally analyzed in routine analyses in genetics and biochemistry. Biochip technology allows the advantage of searching for many loci in one sample at the same time. The protein pattern of a tumor can be demonstrated by using this technology in diseases such as cancer, where several factors and genes are affected, and it is possible to find out more specific and sensitive new cancer markers with this new technology.

Özet

Yirmibirinci yüzyılın başında artık, insan genom projesinin sonuna yaklaşılmıştır. Günümüzde insanoğlu, genom ile ilgili çok daha fazla bilgiye sahiptir. Diğer taraftan, yeni bir teknoloji olan biyoçip teknolojisi kullanıma girmiş ve rutin genom analizlerinde kullanılmaya başlanmıştır. Rutin yapılan genetik ve biyokimyasal analizlerde, genellikle tek bir gen bölgesine veya tek bir proteine bakılmaktadır. Yeni kullanılmaya başlanan biyoçip teknolojisi bir anda, bir örnekte, birçok farklı bölgeye bakabilme avantajı sunmaktadır. Bu teknoloji ile kanser gibi birçok faktörün ve genin etkilendiği hastalık tablolarında tümörün protein kalıbı çıkarılabilmekte, daha özgün ve hassas kanser markırları bulunabilmektedir.

🔖

Cite This Article

GÜRAN, Ş. (2005). New diagnostic approaches into diseases: protein chip technology. Gülhane Tıp Dergisi, Cilt: 47 - Sayı: 3, 243–245. https://ajindex.com/articles/225658

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Peltonen L, Me Kusick VA. Genomics and medicine. Dissecting human disease in the postgenomic era. Science 2001; 291: 1224-1229
  2. Güran Ş. İnsan genom projesi: dünü bugünü ve yarını. Gülhane Tıp Dergisi 2001; 43: 440-443
  3. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Biology of Cell. 4th ed. New York: Garland Science,2002
  4. Connor M, Ferguson-Smith M. Essential Medical Genetics. 5th ed, New York: Blackwell Science, 1997
  5. Chapman K. The protein chip biomarker system from ciphergen biosystems: a novel proteomics platform for rapid biomarker discovery and validation. Biochem Soc Trans 2002; 30: 82-87
  6. Kodadek T. Development of protein- detecting microarrrays and related devices. Trends Biochem Sci 2002; 27: 295-300
  7. Falsey JR, Renil M, Park S, Li S, Lam KS. Peptide and small molecule microarrray for high throughput cell adhesion and functional assays. Bioconjug Chem 2001; 12: 346-353
  8. Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001; 412: 822-826
  9. Kodatek T, Reddy MM, Olivos HJ, Bachawat-Sikder K, Alluri PG. Synthetic molecules as antibody replacements. Ace Chem Res 2004; 37: 711-718
  10. Pandey A, Mann M. Proteomics to study genes and genomes. Nature 2000; 405: 837-846. ll.Washburn MP, Wolters D, Yates JR 3rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001; 19: 242-247
  11. Moore CA, Khoury MJ, Bradley LA. From genetics to genomics using gene-based medicine to prevent disease and promote health in children. Semin Perinatol 2005; 29: 135-143
  12. Zhang L, Yu W, He T, et al. Contribution of human alfa defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 2002; 298: 995-1000
  13. Petricoin EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359:572-577
  14. De Vita VT, Hellman S, Rosenberg SA Cancer, Principles and Practice of Oncology. 4th ed. Philadelphia: JB Lippincott Co, 1993
  15. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomix and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002; 48: 1296-1304
  16. Borsting C, Sanches JJ, Morling N. Multiplex PCR, amplicon size and hybridization efficiency on the NanoChip elec¬ tronic microarray. Int J Legal Med 2004; 118: 75-82
  17. Horsthemke B, Nazlıcan H, Husing J, et al. Somatic mosaicism f